Dual small molecule inhibitors of cancer and angiogenesis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/47 (2006.01) A61K 31/517 (2006.01) C07D 217/24 (2006.01) C07D 221/12 (2006.01) C07D 221/16 (2006.01) C07D 237/30 (2006.01) C07D 239/91 (2006.01) C07D 401/12 (2006.01) C07D 487/04 (2006.01) C07D 491/04 (2006.01) C07D 495/04 (2006.01)

Patent

CA 2568622

The present invention provides analogs and derivatives of thalidomide which inhibit cancer and angiogenesis. The present invention further provides compounds which disrupt microtubule polymerization. The present further provides methods of treating cancers comprising mutant p53.

La présente invention fournit des analogues et des dérivés de la thalidomide qui inhibent le cancer et l~angiogenèse. La présente invention fournit en outre des composés qui interrompent la polymérisation des microtubules. La présente invention fournit de plus des méthodes de traitement des cancers comprenant le mutant p53.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dual small molecule inhibitors of cancer and angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dual small molecule inhibitors of cancer and angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dual small molecule inhibitors of cancer and angiogenesis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2068304

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.